FALCON POINT CAPITAL, LLC - CADENCE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 77 filers reported holding CADENCE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 4.64 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$1,030,000
+43.7%
113,8080.0%0.98%
+28.8%
Q3 2013$717,000
+14.0%
113,808
+23.4%
0.76%
+10.4%
Q2 2013$629,000–92,217–0.69%–
 Download
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q2 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders